Realistic medical lifestyle photograph of a European man in his 50s sitting at home with one hand resting gently on his abdomen and a glass of water nearby, looking mildly uncomfortable but not distressed. Natural home environment, realistic body proportions and skin texture, documentary health photography. No medication branding, no text, no logo, no watermark.

Chapter 4: Blood Sugar, Weight Loss, and Other Effects

One of the major medical effects of Ozempic is its ability to improve blood glucose control in people with type 2 diabetes.

Semaglutide helps the pancreas release insulin when blood glucose is elevated and reduces glucagon signaling in a glucose-dependent manner. Together, these actions can lower blood glucose levels.

For people with diabetes, this can be clinically useful.

But blood sugar can sometimes become too low when semaglutide is combined with certain other diabetes medications, particularly insulin or sulfonylureas.

Symptoms of hypoglycemia can include shakiness, sweating, hunger, dizziness, confusion, rapid heartbeat, and weakness.

This does not mean everyone taking Ozempic will experience low blood sugar. The risk depends partly on what other medications the person is using.

Weight loss is another major effect.

Clinical studies have demonstrated meaningful weight reduction with semaglutide, although the amount varies substantially between individuals.

Weight loss can improve several health measures in people with obesity or overweight, but the medication does not work identically for everyone.

It is also possible for weight to return after treatment is discontinued. Appetite-regulating pathways remain part of normal physiology, so stopping a medication that suppresses appetite can result in increased hunger and weight regain for some people.

This is why long-term weight management often requires a broader approach rather than viewing medication as a temporary shortcut.

Dietary habits, physical activity, sleep, stress, and underlying medical conditions can all influence body weight.

There are also important safety considerations.

Semaglutide carries a boxed warning related to thyroid C-cell tumors based on findings in rodents. It is not known whether this risk applies to humans, but the medication should not be used by people with a personal or family history of medullary thyroid carcinoma or by people with Multiple Endocrine Neoplasia syndrome type 2, according to prescribing information.

Patients should also tell their healthcare professionals about other medications and medical conditions before starting treatment.

Ozempic is a powerful prescription medication, not simply a cosmetic weight-loss injection.

Its benefits and risks depend on the individual receiving it, the reason it is prescribed, the dose, other medications, and the person's underlying health.

That is why using someone else's medication, buying unapproved products, or changing doses without medical supervision can create unnecessary risks.